Biotech firm Regeneron claims to be close to successful development of COVID-19 treatments:
Regeneron said it has developed hundreds of potential medicines that could work against the novel #coronavirus that causes #Covid-19, and that it may enter clinical trials by early summer.
www.statnews.com
I have no expertise in this field, so I have no clue if this is marketing bravado or true hope. But let's ponder that Regeneron succeeds, and is able to deliver via treatments by fall of 2020. Let's also assume that governments and insurance companies will pay a high price for these drugs, because hospitalization and reactive treatment costs are astronomical, if available at all.
How much profit is fair per patient? $500 person? $5000 per person? $50,000 per person? $100,000 per person? (Some drugs on the market now for other diseases have list prices of $100,000 per year.)